have people died from semaglutide Study finds weight loss drug reduced COVID-19 related deaths during the pandemic Cardiovascular Disease | Ozempic® (semaglutide)

What the research actually covers Characterised as the first selective compound of its class (Raun et al., 1998) Comparatively little effect on cortisol and prolactin No human trials measure whether it builds muscle or improves strength Mechanism is well described

The FDA-approved labeling for semaglutide and tirzepatide does not list liver disease as a contraindication, and no dose adjustments are required for hepatic impairment

They also have a CBD that is good

The reconstitution calculator does this math for you if you prefer

Weight loss statistics: The website presents several figures, including "6x more weight loss than exercise and diet alone," "lose an average of 18% of your body weight," and "93% kept the weight off for good." According to fine print on the website, these figures are described as being based on "MEDVi patients over their first 6 months of treatment." The company's own disclosures state that "all claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals." The disclosures further state that "results from compounded medications found on the MEDVi platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations." Customer testimonials: The MEDVi website includes named customer testimonials with specific weight loss figures and outcomes attributed to verified customers